Clinical Trial Update: Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial investigating prevention of the inflammatory response to experimentally induced insomnia symptoms; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Insomnia | EARLY_Phase 1 | Status: COMPLETED